Meeting
2020 Genitourinary Cancers Symposium
A randomized phase II study of erdafitinib (ERDA) versus intravesical chemotherapy (IC) in patients with high-risk nonmuscle invasive bladder cancer (HR-NMIBC) with FGFR mutations or fusions, who recurred after Bacillus Calmette-Guérin (BCG) therapy.
Authors
Gary D. Steinberg
NYU Langone Health, New York, NY
Gary D. Steinberg , Joan Palou-Redorta , Juergen E. Gschwend , Ben Tran , Yohann Loriot , Siamak Daneshmand , Morgan Roupret , Ademi E. Santiago-Walker , Julie C. Switzky , Christopher Major , Mahadi Baig , Qi Xia , James WF Catto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
2019-002449-39
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr TPS603)
Abstract #
TPS603
Poster Bd #
N21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Study of real-world treatment patterns and adherence to bacillus Calmette-Guerin (BCG) in the context of guideline recommendations for patients with high-risk non-muscle invasive bladder cancer (NMIBC).
First Author: Franklin D Gaylis
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer.
First Author: Christopher Gaffney
Poster
2024 ASCO Genitourinary Cancers Symposium
Population based trends in intravesical gemcitabine use among patients with high-risk non-muscle invasive bladder cancer.
First Author: Stephen B. Williams
Poster
2024 ASCO Genitourinary Cancers Symposium
Guiding adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient-derived organoids.
First Author: Martin Egger